Published in Rev Med Brux on March 01, 1987
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med (1999) 2.98
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J (1971) 2.82
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
Glomus tumours of the hand. A retrospective study of 51 cases. J Hand Surg Br (1996) 2.22
TIA-1 and TIAR activate splicing of alternative exons with weak 5' splice sites followed by a U-rich stretch on their own pre-mRNAs. J Biol Chem (2001) 1.96
UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation. EMBO J (2001) 1.81
Hypercalcaemia in B cell chronic lymphocytic leukaemia. Br J Haematol (1994) 1.50
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res (2000) 1.47
Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine. J Pediatr Hematol Oncol (1996) 1.42
Secondary displacement of distal radius fractures treated by bridging external fixation. J Hand Surg Eur Vol (2013) 1.42
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther (2003) 1.40
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. J Immunol (2000) 1.31
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci U S A (2001) 1.31
Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. Int J Cancer (1995) 1.30
Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization. J Pharmacol Exp Ther (2001) 1.28
Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. EORTC Melanoma Cooperative Group. Int J Cancer (1994) 1.27
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J Immunol (2001) 1.24
Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha). Int J Cancer (1994) 1.22
On the release and half-life of S100B protein in the peripheral blood of melanoma patients. Int J Cancer (2001) 1.20
External fixation of the clavicle for fracture or non-union in adults. J Bone Joint Surg Am (1988) 1.16
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. J Immunol (2000) 1.13
Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside triphosphates in human carcinoma cells by high-performance liquid chromatography. Anal Biochem (1999) 1.12
Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. Int J Cancer (1993) 1.10
Intussusception in adults--report of 3 cases. Acta Chir Belg (1985) 1.08
Correlations between clinical presentations of adult trigger digits and histologic aspects of the A1 pulley. J Hand Surg Am (2009) 1.08
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide. Clin Cancer Res (2001) 1.08
Theoretical study of the decrease in the femoral neck anteversion during growth. Cells Tissues Organs (2002) 1.06
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther (2001) 1.05
Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours. Ann Oncol (1999) 1.04
Tissues and bone adhesives--historical aspects. Biomaterials (1998) 1.01
Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori (1980) 1.01
[Fractures and dislocations of the astragalus. Review of 359 cases]. Acta Orthop Belg (1983) 1.01
Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells. Eur J Immunol (2001) 1.00
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci (2000) 1.00
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol (1997) 0.99
Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol (2005) 0.99
Extensor pollicis longus entrapment in a paediatric distal radius fracture. J Hand Surg Br (2005) 0.99
Risk factors and impact of orthopaedic monitoring on the outcome of avascular necrosis of the femoral head in adults with sickle cell disease: 215 patients case study with control group. Orthop Traumatol Surg Res (2011) 0.98
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther (1998) 0.97
Sickle-cell hip necrosis and intraosseous pressure. Orthop Traumatol Surg Res (2009) 0.96
Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. Cancer J Sci Am (1997) 0.96
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol (2000) 0.96
Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients. Int Immunopharmacol (2001) 0.95
Surgical management of melanoma: an EORTC Melanoma Group survey. Ecancermedicalscience (2013) 0.93
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. J Pharmacol Exp Ther (2000) 0.93
Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype. Int J Cancer (1998) 0.93
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration. Cancer Chemother Pharmacol (1998) 0.92
Small external fixation devices for the hand and wrist. Clin Orthop Relat Res (1993) 0.91
Magnetic resonance imaging for irreducible posterolateral knee dislocation. J Orthop Trauma (1997) 0.91
Atypical acute rejection after hand transplantation. Am J Transplant (2008) 0.90
An antigen-targeted approach to adoptive transfer therapy of cancer. Cancer Res (1999) 0.90
Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Biomed Appl (1995) 0.89
Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study. Orthop Traumatol Surg Res (2009) 0.88
Does the normal contralateral wrist provide the best reference for X-ray film measurements of the pathologic wrist? J Hand Surg Am (1996) 0.88
Glutathione depletion increases tyrosinase activity in human melanoma cells. J Invest Dermatol (1993) 0.88
Ultrastructural, cytochemical and biochemical changes occurring during syngeneic macrophage-lymphoma interaction in vitro. Eur J Cancer (1972) 0.88
False aneurysm appearing as delayed ulnar nerve palsy after "minor" penetrating trauma in the forearm. J Trauma (2001) 0.88
S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther (2000) 0.85
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line. Clin Cancer Res (1997) 0.85
CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. Am J Transplant (2008) 0.85
The pin as a percutaneous implant: general and related studies. Orthopedics (1984) 0.85
External minifixation for treatment of closed fractures of the metacarpal bones. J Orthop Trauma (1991) 0.85
External fixation of wrist fractures. Orthopedics (1984) 0.85
Electromagnetic stimulation of fracture repair. Influence on healing of fresh fractures. Acta Orthop Belg (1979) 0.84
Production of the effector molecule thymidine by human lung alveolar macrophages. Eur J Cancer Clin Oncol (1984) 0.84
Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. Eur J Haematol (1994) 0.84
Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG). Melanoma Res (1995) 0.84
Biomechanical properties and design considerations in upper extremity external fixation. Hand Clin (1993) 0.84
Measurement of the stiffness of fracture callus in vivo. A theoretical study. J Biomech (1972) 0.83
Photostability of sunscreen products influences the efficiency of protection with regard to UV-induced genotoxic or photoageing-related endpoints. Br J Dermatol (2004) 0.83
Treatment of forearm fractures by Hoffman external fixation. A study of 93 patients. Clin Orthop Relat Res (1991) 0.83
External fixation pin: an in vitro general investigation. Orthopedics (1987) 0.83
Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer (1971) 0.83
Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor. Br J Cancer (1995) 0.83
Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats. J Pharmacol Exp Ther (1995) 0.83
Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survival. Oncogene (2007) 0.83
[Corrosion of a Sherman plate implanted on the humerus over a 48-year period. Clinical and microscopic study]. Acta Orthop Belg (1974) 0.83
A biomechanical study of the ulnar nerve at the elbow. J Hand Surg Br (1995) 0.83
Functional MRI activation of somatosensory and motor cortices in a hand-grafted patient with early clinical sensorimotor recovery. Eur Radiol (2005) 0.82
Cigarette smoking-related persistent polyclonal B lymphocytosis. A premalignant state. Arch Pathol Lab Med (1987) 0.82
A finite-element analysis of Kienbock's disease. J Hand Surg Eur Vol (2008) 0.82
[Tubular inclusions in the lymphocytes in a case of "hairy cells leukemia" (author's transl)]. Pathol Biol (Paris) (1976) 0.82
[Sarcoïdosis and angioimmunoblastic lymphadenopathy with secondary immunoblastic sarcoma (author's transl)]. Sem Hop (1981) 0.82
[Treatment by osteotaxis of diaphyseal fractures of the tibia: 115 cases]. Acta Orthop Belg (1973) 0.82
A new trick for end-to-end anastomosis in microvascular surgery. Modified Harashina procedure. J Reconstr Microsurg (1984) 0.81
Twenty years experience in fracture healing measurement with strain gauges. Orthopedics (1984) 0.81
Prolonged survival after resection of a malignant melanoma metastatic to the stomach. Cancer (1988) 0.81
[Large abdominal wall reconstruction by free flap after recurrence of a dermatofibrosarcoma protuberans]. Ann Chir Plast Esthet (1996) 0.81
[Implants in bone surgery. Historical survey]. Acta Orthop Belg (1974) 0.81
[Desmoid tumor - transformation into fibrosarcoma (author's transl)]. Dermatologica (1981) 0.80
[The Niemann-Pick cell. Aspects in optical and ultrastructural cytology]. Pathol Biol (Paris) (1973) 0.80
[Study of consolidation of fractures by deformation gauges in clinical medicine]. Acta Orthop Belg (1968) 0.80